TOKYO -- Takeda Pharmaceutical CEO Christophe Weber promised greater cost savings from the company's purchase of Irish drugmaker Shire, lifting the savings target by 43% versus its earlier forecast.
Companies
Takeda promises more cost savings from Shire acquisition
Japanese drugmaker forecasts sales jump and lower profit in 'critical' 2019
Pharmaceutical maker Takeda says improvements in its supply chain, sales and marketing, and administrative efficiency will produce greater cost savings than it initially predicted.
Read Next
Latest on Companies
